| scholarly article | Q13442814 |
| P50 | author | Michael von Bergwelt-Baildon | Q47158294 |
| David Sherr | Q56245965 | ||
| Lee M. Nadler | Q117474702 | ||
| Joachim Schultze | Q1690457 | ||
| P2093 | author name string | Britta Maecker | |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 333-336 | |
| P577 | publication date | 2005-06-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1. | |
| P478 | volume | 115 |
| Q35903062 | A Three-Gene Assay for Monitoring Immune Quiescence in Kidney Transplantation |
| Q36593641 | A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis |
| Q38599586 | Analogue peptides for the immunotherapy of human acute myeloid leukemia. |
| Q36240201 | Antigen-specific cellular immunotherapy of leukemia. |
| Q48371221 | CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides. |
| Q38113268 | CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application |
| Q36331221 | Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come |
| Q51534488 | Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis. |
| Q37610312 | In silico methods for predicting T-cell epitopes: Dr Jekyll or Mr Hyde? |
| Q40175703 | New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice |
| Q57556467 | Rare naturally occurring immune responses to three epitopes from the widely expressed tumour antigens hTERT and CYP1B1 in multiple myeloma patients |
| Q37259608 | Targeting cytochrome P450 CYP1B1 with a therapeutic cancer vaccine |
Search more.